Home 
Today's Top Picks 
Top Performers 
Watchlist 
My Robo Portfolios 
ETF Zone 
Help & Tutorial 
Cancel anytime
- Chart
- Upturn Summary
- Highlights
- Valuation
Upturn AI SWOT - About
Zivo Bioscience Inc. Warrants (ZIVOW)
- BUY Advisory
- SELL Advisory (Profit)
- SELL Advisory (Loss)
- Profit
- Loss
- Pass (Skip investing)
Stock price based on last close (see disclosures)
- ALL
- YEAR
- MONTH
- WEEK
Upturn Advisory Summary
08/12/2025: ZIVOW (1-star) is currently NOT-A-BUY. Pass it for now.
Upturn Star Rating
Not Recommended Performance
These Stocks/ETFs, based on Upturn Advisory, consistently fall short of market performance, signaling caution before investing.
Number of Analysts
0 Analysts rated it
Very few follow this stock; limited insights, higher-risk early investing.
Analysis of Past Performance
Type Stock | Historic Profit -44.08% | Avg. Invested days 25 | Today’s Advisory PASS |
Upturn Star Rating | Upturn Advisory Performance  2.0 | Stock Returns Performance  1.0 |
| Profits based on simulation | Last Close 08/12/2025 |
Key Highlights
Company Size Small-Cap Stock | Market Capitalization 35.33M USD | Price to earnings Ratio - | 1Y Target Price - |
Price to earnings Ratio - | 1Y Target Price - | ||
Volume (30-day avg) - | Beta 0.04 | 52 Weeks Range 0.12 - 2.38 | Updated Date 05/26/2025 |
52 Weeks Range 0.12 - 2.38 | Updated Date 05/26/2025 | ||
Dividends yield (FY) - | Basic EPS (TTM) - |
Earnings Date
Report Date - | When - | Estimate - | Actual - |
Profitability
Profit Margin - | Operating Margin (TTM) -13411.4% |
Management Effectiveness
Return on Assets (TTM) -948.38% | Return on Equity (TTM) -3956.02% |
Valuation
Trailing PE - | Forward PE - | Enterprise Value - | Price to Sales(TTM) - |
Enterprise Value - | Price to Sales(TTM) - | ||
Enterprise Value to Revenue - | Enterprise Value to EBITDA - | Shares Outstanding - | Shares Floating 1365620 |
Shares Outstanding - | Shares Floating 1365620 | ||
Percent Insiders - | Percent Institutions - |
Upturn AI SWOT
Zivo Bioscience Inc. Warrants
Company Overview
History and Background
Zivo Bioscience, Inc. is a biotechnology company focused on developing proprietary therapeutics and nutritional products derived from algae. The warrants are derivatives related to the underlying ZIVO stock.
Core Business Areas
- Therapeutics Development: Focuses on developing algae-based therapeutics for human and animal health, particularly for inflammatory and immune disorders.
- Nutritional Products: Develops algae-based nutritional ingredients and products for animal feed and human consumption.
Leadership and Structure
Details on leadership are scarce for the warrants themselves, as they are a derivative. Focus is on Zivo Bioscience, Inc.'s leadership.
Top Products and Market Share
Key Offerings
- ZIVO Algae Platform: The core technology platform used to develop various products. The market share data is difficult to quantify directly for the warrant because it's a derivative. Competitors include companies developing alternative protein sources and immunotherapies for animals.
Market Dynamics
Industry Overview
The biotechnology industry is characterized by high R&D costs, long development timelines, and regulatory hurdles. The market for algae-based products is growing, driven by increasing demand for sustainable and healthy food and feed ingredients.
Positioning
Zivo Bioscience aims to carve a niche in the market by leveraging its proprietary algae platform to develop innovative therapeutics and nutritional products. Competitive advantages may stem from the uniqueness of its algae strains and intellectual property.
Total Addressable Market (TAM)
The TAM for algae-based products is estimated to be in the billions of dollars. Zivo Bioscience is positioned to capture a portion of this market through its innovative products and partnerships.
Upturn SWOT Analysis
Strengths
- Proprietary algae platform
- Potential for innovative therapeutics and nutritional products
- Focus on sustainable and healthy ingredients
Weaknesses
- High R&D costs
- Long development timelines
- Regulatory hurdles
- Limited commercialization experience
- Reliance on securing funding
Opportunities
- Growing demand for algae-based products
- Partnerships with established companies
- Expansion into new markets
- Potential for breakthrough therapeutics
Threats
- Competition from established players
- Regulatory changes
- Market acceptance of algae-based products
- Failure to secure funding
- Clinical trial failures
Competitors and Market Share
Key Competitors
- MDLZ
- NUTR
- DSM
- CPB
- ADM
Competitive Landscape
Zivo Bioscience faces significant competition from established companies in the biotechnology, food, and animal feed industries. Its success depends on its ability to differentiate its products and secure partnerships.
Growth Trajectory and Initiatives
Historical Growth: Growth trends are linked to Zivo Bioscience Inc. 's overall progress in R&D, clinical trials, and commercialization efforts.
Future Projections: Future projections depend on the success of Zivo Bioscience Inc. 's pipeline and the market adoption of its products. Analyst estimates would reflect outlook for ZIVO.
Recent Initiatives: Recent initiatives may include new product development, clinical trial progress, and partnerships.
Summary
Zivo Bioscience Inc. Warrants are speculative investments, their value highly dependent on the success of the underlying Zivo Bioscience Inc. company. The warrants offer potential upside if Zivo's algae-based products gain market traction. However, they also carry significant risk due to the uncertainties inherent in biotechnology development and commercialization, as well as, Zivo's relatively small size in comparison to competitors. Investors should carefully consider their risk tolerance before investing in these warrants.
Peer Comparison
Sources and Disclaimers
Data Sources:
- SEC Filings
- Company Press Releases
- Analyst Reports
- Market Research Reports
Disclaimers:
This analysis is for informational purposes only and does not constitute financial advice. Investment decisions should be based on individual research and consultation with a qualified financial advisor.
AI Summarization is directionally correct and might not be accurate.
Summarized information shown could be a few years old and not current.
Fundamental Rating based on AI could be based on old data.
AI-generated summaries may have inaccuracies (hallucinations). Please verify the information before taking action.
About Zivo Bioscience Inc. Warrants
Exchange NASDAQ | Headquaters Troy, MI, United States | ||
IPO Launch date 2021-05-28 | President, CEO & Chairman of the Board Mr. John Bernard Payne | ||
Sector Healthcare | Industry Biotechnology | Full time employees 7 | Website https://www.zivobioscience.com |
Full time employees 7 | Website https://www.zivobioscience.com | ||
ZIVO Bioscience, Inc., together with its subsidiaries, engages in licensing and selling natural bioactive ingredients derived from its proprietary algae cultures to animal, human, and dietary supplement and medical food manufacturers. The company operates in the biotech and agtech sectors, with an intellectual property portfolio comprising proprietary algal and bacterial strains, biologically active molecules and complexes, production techniques, cultivation techniques, and patented or patent-pending inventions for applications in human and animal health. It offers poultry gut health, avian influenza, bovine mastitis, canine joint health, human immune modification, human functional food ingredients, algal biomass for human food, and biomass for supporting skin health and anti-aging. The company was formerly known as Health Enhancement Products, Inc. and changed its name to ZIVO Bioscience, Inc. in October 2014. ZIVO Bioscience, Inc. is headquartered in Troy, Michigan.
Note: This website is maintained by Upturn Corporation, which is an investment adviser registered with the U.S. Securities and Exchange Commission. Such registration does not imply a certain level of skill or training. Investing in securities has risks. Past performance is no guarantee of future returns. No assurance is provided as to any particular investment return, and you may lose money using our services. You are strongly advised to consult appropriate counsel before making any investments in companies you learn about through our services. You should obtain appropriate legal, tax, investment, accounting, and other advice that takes into account your investment portfolio and overall financial situation. You are solely responsible for conducting due diligence on a potential investment. We do not affect trades for you. You will select your own broker through which to transact. Investments are not FDIC insured, they are not guaranteed, and they may lose value. Please see the Privacy Policy, Terms of Use, and Disclosure for more information.